Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Psilocybin Tied to Lower Inflammation in Parkinson's Trial

(MedPage Today) -- Markers of systemic inflammation and mitochondrial stress were reduced after psilocybin therapy in Parkinson's disease patients with mood dysfunction, a small nonrandomized trial showed. Relative to baseline, an inflammatory...

Psilocybin Tied to Lower Inflammation in Parkinson's Trial

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Wednesday 21 October →